3,505 Shares in HCA Healthcare, Inc. (NYSE:HCA) Purchased by Union Bancaire Privee UBP SA

Union Bancaire Privee UBP SA acquired a new position in HCA Healthcare, Inc. (NYSE:HCAFree Report) during the 4th quarter, Holdings Channel reports. The fund acquired 3,505 shares of the company’s stock, valued at approximately $1,060,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Legacy Investment Solutions LLC purchased a new position in HCA Healthcare in the 3rd quarter valued at about $39,000. Capital Performance Advisors LLP purchased a new position in HCA Healthcare in the 3rd quarter valued at about $41,000. Canoe Financial LP purchased a new position in HCA Healthcare in the 3rd quarter valued at about $41,000. Activest Wealth Management lifted its holdings in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. lifted its holdings in HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on HCA. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price objective for the stock from $400.00 to $320.00 in a report on Monday, November 25th. TD Cowen cut their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Oppenheimer increased their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. Cantor Fitzgerald reiterated an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a report on Monday, January 27th. Finally, KeyCorp dropped their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $385.67.

Read Our Latest Analysis on HCA Healthcare

HCA Healthcare Stock Down 1.7 %

Shares of NYSE:HCA opened at $316.07 on Monday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a 50 day moving average of $313.53 and a two-hundred day moving average of $350.82. The company has a market capitalization of $78.49 billion, a price-to-earnings ratio of 14.39, a price-to-earnings-growth ratio of 1.10 and a beta of 1.64.

HCA Healthcare (NYSE:HCAGet Free Report) last released its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the company posted $5.90 earnings per share. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.91%. HCA Healthcare’s dividend payout ratio (DPR) is 13.11%.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.